XML 35 R22.htm IDEA: XBRL DOCUMENT
v3.19.1

Equity Plan Awards | 12 Months Ended
--- | ---
Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Equity Plan Awards | (12) Equity Plan Awards Under the Company’s Equity Incentive Plan of 1993, as amended (“the Plan”), all employees are eligible to receive non-assignable and non-transferable restricted stock, options to purchase common stock, and other forms of equity. As of December 31, 2018, the number of securities remaining available for future issuance under the Plan is 1,568,888. Incentive Stock Option Plans (“ISOP”) Under the terms of the Company’s ISOP, under which options to purchase common stock can be issued, all employees are eligible to receive non-assignable and non-transferable options to purchase shares. The exercise price of any option may not be less than the fair market value of the shares on the date of grant; provided, however, that the exercise price of any option granted to an eligible employee owning more than 10% of the outstanding common stock may not be less than 110% of the fair market value of the shares underlying such option on the date of grant. No options granted may be exercisable more than ten years after the date of grant. In 2018, 2017 and 2016, no options were granted. Option activity within each plan is as follows:
|  | Incentive Stock Option Plans |  |  | Weighted Average Price Per Share |  |  | Exercisable Weighted Average Price Per Share |
Balance outstanding, December 31, 2015 |  |  | 626,845 |  |  | $ | 9.25 |  |  | $ | 7.73 |
Options exercised, |  |  | (58,900 | ) |  | $ | 7.50 |  |  |  |  |
Options forfeited, |  |  | (26,040 | ) |  |  | 11.49 |  |  |  |  |
Balance outstanding, December 31, 2016 |  |  | 541,905 |  |  | $ | 9.33 |  |  | $ | 7.97 |
Options exercised, |  |  | (55,979 | ) |  | $ | 8.37 |  |  |  |  |
Options forfeited, |  |  | (13,143 | ) |  |  | 11.49 |  |  |  |  |
Balance outstanding, December 31, 2017 |  |  | 472,783 |  |  | $ | 9.38 |  |  | $ | 9.38 |
Options exercised, |  |  | (88,719 | ) |  | $ | 10.62 |  |  |  |  |
Options forfeited, |  |  | — |  |  |  | — |  |  |  |  |
Balance outstanding, December 31, 2018 |  |  | 384,064 |  |  | $ | 9.10 |  |  | $ | 9.10 |
Information relating to stock options at December 31, 2018 summarized by exercise price is as follows:
|  | Outstanding Weighted Average |  |  | Exercisable Weighted Average |
Exercise Price Per Share |  | Shares |  |  | Remaining Life (Months) |  |  | Exercise Price |  |  | Shares |  |  | Exercise Price |
Incentive Stock Option Plan: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
$7.50 |  |  | 229,545 |  |  |  | 23 |  |  | $ | 7.50 |  |  |  | 229,545 |  |  | $ | 7.50 |
$11.32-$14.75 |  |  | 154,519 |  |  |  | 70 |  |  | $ | 11.48 |  |  |  | 154,519 |  |  | $ | 11.48 |
|  |  | 384,064 |  |  |  | 42 |  |  | $ | 9.10 |  |  |  | 384,064 |  |  | $ | 9.10 |
During 2017 and 2016, the Company recognized stock-based compensation expense related to incentive stock options of $345, and $354, respectively. During 2018, the Company did not recognized stock-based compensation expense related to incentive stock options. The weighted average exercise prices for options granted and exercisable and the weighted average remaining contractual life for options outstanding as of December 31, 2018 and 2017 was as follows:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (Months) |  |  | Intrinsic Value (thousands) |
As of December 31, 2018: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Incentive Stock Option Plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding |  |  | 384,064 |  |  | $ | 9.10 |  |  |  | 42 |  |  | $ | 2,338 |
Vested |  |  | 384,064 |  |  | $ | 9.10 |  |  |  | 42 |  |  | $ | 2,338 |
Exercisable |  |  | 384,064 |  |  | $ | 9.10 |  |  |  | 42 |  |  | $ | 2,338 |
As of December 31, 2017: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Incentive Stock Option Plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding |  |  | 472,783 |  |  | $ | 9.38 |  |  |  | 57 |  |  | $ | 4,853 |
Vested |  |  | 472,783 |  |  | $ | 9.38 |  |  |  | 57 |  |  | $ | 4,853 |
Exercisable |  |  | 472,783 |  |  | $ | 9.38 |  |  |  | 57 |  |  | $ | 4,853 |
The total intrinsic value of options exercised during 2018, 2017 and 2016 was $955, $545, and $493, respectively. Cash received from stock options exercised during 2018, 2017, and 2016 was $951, $468, and $442, respectively. Nonstatutory Stock Options (“NSSO”) The Company did not grant any non-statutory stock options during the three years ended December 31, 2018. Common Stock Grants During 2018, the Company issued a total of 282,030 shares of common stock to certain employees and non-executive board members. Of these, 25,312 shares vest immediately, 1,017 shares will vest 6 months from the employee’s employment date, 1,017 shares will vest eighteen months from the employee’s employment date, 5,250 shares will vest two years from the employee’s employment date, and majority of the balance will cliff vest after three years of service. The fair values of the grants range from $16.85 to $23.60 per share based on the publicly traded share prices as of the market close on the date of grants. The total fair value of $5,651 is being recognized over the vesting period, which is representative of the related service periods. During 2018, 33,269 shares of common stock granted to employees were forfeited. During 2017, the Company issued a total of 290,977 shares of common stock to certain employees and non-executive board members. Of these, 26,820 shares vest immediately, 1,300 shares will vest one-half each year on the anniversaries of the employee’s employment date, 1,782 shares will vest two years from the employee’s employment date, and the balance will cliff vest after three years of service. The fair values of the grants range from $14.92 to $19.90 per share based on the publicly traded share prices as of the market close on the date of grants. The total fair value of $4,726 is being recognized over the vesting period, which is representative of the related service periods. During 2017, 20,815 shares of common stock granted to employees were forfeited. A status summary of non-vested shares as of December 31, 2018 and 2017, are presented below:
|  | December 31, 2018 |  |  | December 31, 2017 |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |  |  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |
Nonvested shares at January 1st |  |  | 391,753 |  |  | $ | 15.61 |  |  |  | 324,756 |  |  | $ | 14.75 |
Granted |  |  | 282,030 |  |  |  | 20.21 |  |  |  | 290,977 |  |  |  | 16.24 |
Vested |  |  | (53,304 | ) |  |  | 17.06 |  |  |  | (203,165 | ) |  |  | 15.14 |
Forfeited |  |  | (33,269 | ) |  |  | 17.29 |  |  |  | (20,815 | ) |  |  | 15.29 |
Nonvested shares at December 31st |  |  | 587,210 |  |  | $ | 17.59 |  |  |  | 391,753 |  |  | $ | 15.61 |
During 2018, 2017 and 2016, the Company recognized stock-based compensation expense related to restricted shares of $3,657, $2,705, and $1,630, respectively. Performance Based Stock Grants During the year ended December 31, 2018, the Company issued a total of 130,332 performance based shares to employees. The shares granted during 2018 have an average fair value of $18.74. The fair value was determined by using the publicly traded share price as of the market close on the date of grant. The Company will recognize as expense the value of the performance based shares over the required service period from grant date. The shares will cliff vest on March 9, 2021 with a measurement period commencing January 1, 2018 and ending December 31, 2020. Eighty percent of these performance based shares are based upon the financial performance of the Company, specifically, an earnings before income taxes (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30% . The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2017 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for recording less than the targeted performance and to increase to a maximum of 200% for achieving in excess of the targeted performance. During the year ended December 31, 2017, the Company issued a total of 128,594 performance based shares to employees. The shares granted during 2017 have an average fair value of $15.43. The fair value was determined by using the publicly traded share price as of the date of grant. The Company will recognize as expense the value of the performance based shares over the required service period from grant date. The shares will cliff vest on February 8, 2020 with a measurement period commencing January 1, 2017 and ending December 31, 2019. Eighty percent of these performance based shares are based upon the financial performance of the Company, specifically, an earnings before income taxes (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30% . The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2016 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for recording less than the targeted performance and to increase to a maximum of 200% for achieving in excess of the targeted performance. On January 6, 2016, the Company granted a total of 52,170 performance based shares that will cliff vest on January 6, 2019 with a measurement period commencing January 1, 2016 through December 31, 2018, provided that the participating employees are continuously employed by the Company during the vesting period. Eighty percent of these performance based shares are based upon financial performance of the Company, specifically, an earnings before income tax (“EBIT”) goal weighted at 50% and a net sales goal weighted at 30%. The remaining 20% of performance based shares are based upon AVD stock price appreciation over the same performance measurement period. The EBIT and net sales goals measure the relative growth of the Company’s EBIT and net sales for the performance measurement period, as compared to the median growth of EBIT and net sales for an identified peer group. The stockholder return goal measures the relative growth of the fair market value of the Company’s stock price over the performance measurement period, as compared to that of the Russell 2000 Index and the median fair market value of the common stock of the comparator companies, identified in the Company’s 2015 Proxy Statement. All parts of these awards vest in three years, but are subject to reduction to a minimum (or even zero) for meeting less than the targeted performance and to increase to a maximum of 200% for meeting in excess of the targeted performance. As of December 31, 2018, the performance based shares related to EBIT and net sales have an average fair value of $18.27 per share. The fair value was determined by using the publicly traded share price as of the market close on the date of grant. The performance based shares related to the Company’s stock price have an average fair value of $15.43 per share. The fair value was determined by using the Monte Carlo valuation method. For awards with performance conditions, the Company recognizes share-based compensation cost on a straight-line basis for each performance criteria over the implied service period. As of December 31, 2017, the performance based shares related to EBIT and net sales have an average fair value of $16.10 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The performance based shares related to the Company’s stock price have an average fair value of $12.60 per share. The fair value was determined by using the Monte Carlo valuation method. For awards with performance conditions, the Company recognizes share-based compensation cost on a straight-line basis for each performance criteria over the implied service period. As of December 31, 2016, the performance based shares related to EBIT and net sales have an average fair value of $15.08 per share. The fair value was determined by using the publicly traded share price as of the date of grant. The performance based shares related to the Company’s stock price have an average fair value of $11.63 per share. The fair value was determined by using the Monte Carlo valuation method. For awards with performance conditions, the Company recognizes share-based compensation cost on a straight-line basis for each performance criteria over the implied service period. During 2018, 2017 and 2016, the Company recognized stock-based compensation expense related to performance based shares of $2,148, $1,248, and $995, respectively. In 2018, the Company assessed the likelihood of achieving the performance measures based on peer group information currently available for the performance based shares granted in 2016. Based on the performance thus far, the Company has concluded that it is likely that the performance measure based on EBIT and net sales will be met at 200% of targeted performance and have recorded the related additional expense in 2018. The performance shares based on market price are expected to be met at 125% of targeted performance. The effect of market conditions for performance shares based on market are included in the grant date fair value valuation and no additional expenses were recognized in 2018. As of December 31, 2018, the Company had approximately $2,565 of unamortized stock-based compensation expenses related to unvested performance based shares. This amount will be recognized over the weighted-average period of 1.9 years. This projected expense will change if any performance based shares are granted or cancelled prior to the respective reporting periods or if there are any changes required to be made for estimated forfeitures. A summary of non-vested shares as of December 31, 2018 and 2017, is presented below:
|  | December 31, 2018 |  |  | December 31, 2017 |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |  |  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |
Nonvested shares at January 1st |  |  | 186,057 |  |  | $ | 14.93 |  |  |  | 119,022 |  |  | $ | 14.18 |
Granted |  |  | 130,332 |  |  |  | 18.74 |  |  |  | 128,594 |  |  |  | 15.43 |
Vested |  |  | (22,857 | ) |  |  | 11.90 |  |  |  | (48,046 | ) |  |  | 14.92 |
Forfeited |  |  | (6,455 | ) |  |  | 16.22 |  |  |  | (13,513 | ) |  |  | 13.08 |
Nonvested shares at December 31st |  |  | 287,077 |  |  | $ | 16.87 |  |  |  | 186,057 |  |  | $ | 14.93 |
Performance Incentive Stock Option Plan For the three years ended December 31, 2018, the Company did not grant any employees performance incentive stock options to acquire shares of common stock. Performance option activity is as follows:
|  | Incentive Stock Option Plans |  |  | Weighted Average Price Per Share |  |  | Exercisable Weighted Average Price Per Share |
Balance outstanding, December 31, 2016 |  |  | 82,334 |  |  | $ | 11.49 |  |  | $ | — |
Options forfeited |  |  | (668 | ) |  |  | 11.49 |  |  |  | — |
Balance outstanding, December 31, 2017 |  |  | 81,666 |  |  | $ | 11.49 |  |  | $ | 11.49 |
Additional vesting based on performance |  |  | 77,598 |  |  |  | 11.49 |  |  |  | 11.49 |
Options exercised |  |  | (18,853 | ) |  |  | 11.49 |  |  |  | 11.49 |
Balance outstanding, December 31, 2018 |  |  | 140,411 |  |  | $ | 11.49 |  |  | $ | 11.49 |
Information relating to performance stock options at December 31, 2018 is summarized by exercise price is as follows:
|  | Outstanding Weighted Average |  |  | Exercisable Weighted Average |
Exercise Price Per Share |  | Shares |  |  | Remaining Life (Months) |  |  | Exercise Price |  |  | Shares |  |  | Exercise Price |
Performance Incentive Stock Option Plan: |  |  | 140,411 |  |  |  | 72 |  |  | $ | 11.49 |  |  |  | 140,411 |  |  | $ | 11.49 |
The weighted average exercise price for performance options granted and exercisable and the weighted average remaining contractual life for performance options outstanding as of December 31, 2018 and 2017 was as follows:
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (Months) |  |  | Intrinsic Value (thousands) |
As of December 31, 2018: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Performance Incentive Stock Option Plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding |  |  | 140,411 |  |  | $ | 11.49 |  |  |  | 72 |  |  | $ | 520 |
Expected to Vest |  |  | 140,411 |  |  | $ | 11.49 |  |  |  | 72 |  |  | $ | 520 |
Exercisable |  |  | 140,411 |  |  | $ | 11.49 |  |  |  | 72 |  |  | $ | 520 |
As of December 31, 2017: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Performance Incentive Stock Option Plans: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding |  |  | 81,666 |  |  | $ | 11.49 |  |  |  | 84 |  |  | $ | 666 |
Expected to Vest |  |  | 81,666 |  |  | $ | 11.49 |  |  |  | 84 |  |  | $ | 666 |
Exercisable |  |  | 81,666 |  |  | $ | 11.49 |  |  |  | 84 |  |  | $ | 666 |
During 2017 and 2016, the Company recognized stock-based compensation expense related to performance incentive stock options of $416 and $188, respectively. During 2018, the Company did not recognize stock-based compensation expense related to performance incentive stock options.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration